Soroban Capital Partners’s Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-202,507
Closed -$177K 79
2021
Q1
$177K Buy
+202,507
New +$182K ﹤0.01% 113

Other funds holding AAC.WS

Soroban Capital Partners's AAC.WS Position: Q2 2021 in Review

Soroban Capital Partners sold out of Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AAC.WS) in Q2 2021, closing a stake of 202,507 shares — an estimated $177K sold.

Soroban Capital Partners first reported a position in AAC.WS in Q1 2021 and held it in 1 quarter. The position peaked at $177K in Q1 2021. 68 funds tracked by Wall St. Rank hold AAC.WS as of Q2 2021.

  • Soroban Capital Partners reported no remaining Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2021 after selling out during the quarter.
  • Soroban Capital Partners sold 202,507 Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2021, an estimated $177K.
  • Soroban Capital Partners first reported a position in Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 1 quarter.
  • Soroban Capital Partners's Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $177K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2021.

Based on Soroban Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.